Novel compounds target formation of amyloid peptides

08/4/2013 | Yahoo

A study published in Nature Communications has uncovered the mechanisms behind two types of compounds that could help fight Alzheimer's disease. Researchers are testing the two compounds to target gamma secretase, the enzyme that cuts longer proteins into components including the form of amyloid peptide that aggregates into toxic plaques. The latest research helps explain how the new compounds interact with gamma secretase.

View Full Article in:


Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN